Rudolf Werner
Overview
Explore the profile of Rudolf Werner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wegen S, Nestle U, Zamboglou C, Spohn S, Nicolay N, Unterrainer L, et al.
Strahlenther Onkol
. 2024 Aug;
200(11):931-941.
PMID: 39120747
Background: The use of positron-emission tomography (PET)/computed tomography (CT) in radiation therapy (RT) has increased. Radiation oncologists (RadOncs) have access to PET/CT with a variety of tracers for different tumor...
2.
Guggenberger K, Vogt M, Song J, Frohlich M, Schmalzing M, Venhoff N, et al.
Rheumatology (Oxford)
. 2024 Jan;
64(2):842-848.
PMID: 38197587
Objective: Giant cell arteritis (GCA) is a large vessel vasculitis, typically involving the aorta and its branches with predilection for the scalp arteries. Intracranial involvement is still part of ongoing...
3.
Werner R, Haug A, Buske C, Heidegger S, Illert A, Bassermann F, et al.
Nuklearmedizin
. 2024 Jan;
63(2):57-61.
PMID: 38190998
C-X-C motif chemokine receptor 4 (CXCR4) is overexpressed in a multitude of cancers, including neoplasms of hematopoietic origin. This feature can be leveraged by a theranostic approach, which provides a...
4.
Serfling S, Buck A, Rowe S, Higuchi T, Werner R
Nuklearmedizin
. 2023 Dec;
63(2):76-77.
PMID: 38134943
We report on a patient diagnosed with Hodgkin Lymphoma who was scheduled for [F]FDG PET/CT as part of routine follow-up after treatment with two cycles of chemotherapy and mediastinal external...
5.
Heidemeier A, Schloetelburg W, Thurner A, Metz C, Heidemeier H, Rasche L, et al.
Eur J Radiol
. 2022 Aug;
155:110493.
PMID: 36027759
Purpose: We tested a novel multi-parametric (mp) whole body (WB)-MRI evaluation algorithm for medullary lesions in comparison to positron emission tomography (PET) radiotracers F-fluorodeoxyglucose (F-FDG) and C-methionine (C-MET). Methods And...
6.
Bogelein A, Stolzenburg A, Eiring P, Luckerath K, Munawar U, Werner R, et al.
Leuk Lymphoma
. 2022 Jul;
63(10):2393-2402.
PMID: 35802888
Chemokine receptors represent novel targets for treatment of multiple myeloma (MM). However, CXCR4 expression appears to be highly dynamic. This study investigated the impact of commonly used anti-myeloma agents on...
7.
Hartrampf P, Werner R, Buck A
Zentralbl Chir
. 2022 Jun;
147(3):249-255.
PMID: 35705086
Neuroendocrine neoplasms (NEN) are rare, heterogeneous, and typically slowly growing tumours. The most common location is the gastro-entero-pancreatic system (GEP-NEN). NENs are classified according to their proliferative activity (Ki-67 index,...
8.
Bockle D, Tabares P, Zhou X, Schimanski S, Steinhardt M, Bittrich M, et al.
Br J Haematol
. 2022 May;
198(3):515-522.
PMID: 35582835
Measurement of minimal residual disease (MRD) by next-generation flow cytometry (NGF) is an important tool to define deep responses in multiple myeloma (MM). However, little is known about the value...
9.
Lewis R, Habringer S, Kircher M, Hefter M, Peuker C, Werner R, et al.
EJNMMI Res
. 2021 Aug;
11(1):77.
PMID: 34417915
Background: The chemokine receptor CXCR4 is frequently overexpressed and associated with adverse prognosis in most hematopoietic malignancies and solid cancers. Recently, CXCR4 molecular imaging using the CXCR4-specific positron emission tomography...
10.
Christoph E, Hayakawa N, Arias-Loza P, Wakabayashi H, Werner R, Shinaji T, et al.
Porto Biomed J
. 2020 Apr;
2(5):193.
PMID: 32258655
No abstract available.